Every Form 4 that Concentra Group Holdings Parent, Inc. (CON) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CON and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CON filings page.
Concentra Group Holdings Parent, Inc. (CON) reported that director Robert A. Ortenzio and related trusts disposed of common stock to the company on August 21, 2026, in transactions already previously reported. The amendment corrects administrative errors and adds an omitted indirect holding, without introducing new transactions. Under a Stock Repurchase Agreement, the company agreed to repurchase an aggregate of 1,000,000 shares at $34.65 per share, including 770,000 shares held directly by Ortenzio and 230,000 shares held through trusts for his descendants. After these dispositions, Ortenzio directly holds 4,663,794 shares, with additional indirect holdings through several family trusts, including 882,115 shares in the Descendants Trust and 196,286 or 206,286 shares in each of several 2014 trusts. A separate 503,455-share indirect holding in the Rocco A. Ortenzio Separate Descendants Trust was also reported as a holding entry, with no change in beneficial ownership. The Audit Committee of the board, consisting solely of Non-Employee Directors, approved the dispositions for exemption under Rule 16b-3(e).
Concentra Group Holdings Parent, Inc. (CON) entered into a Stock Repurchase Agreement under which it purchased an aggregate of 1,000,000 shares of common stock at $34.65 per share from director Robert A. Ortenzio and related trusts. Ortenzio disposed of 770,000 shares held directly and 230,000 shares held indirectly through family trusts. After these dispositions, he holds 4,763,794 shares directly, with additional shares held indirectly through the named trusts. The Audit Committee of Concentra’s board, composed solely of Non-Employee Directors, approved the transactions for exemption from Section 16(b) under Rule 16b-3(e).
Concentra Group Holdings Parent, Inc. director Robert A. Ortenzio reported an open-market sale of 130,000 shares of common stock on 2026-08-03 at a weighted average price of $31.8412 per share, with individual trade prices between $31.65 and $32.035. The shares were sold indirectly by The Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio, which held 503,455 shares after the transaction. He also reported 5,533,794 shares held directly and additional indirect holdings through several family trusts, and indicated the transaction was carried out under a trading plan.
Concentra Group Holdings Parent, Inc. director Robert A. Ortenzio reported an indirect open-market sale of 130,000 shares of common stock on July 1, 2026 at a weighted average price of $30.4969 per share. The sale was executed by The Rocco A. Ortenzio Separate Descendants Trust for the benefit of Robert Ortenzio, which held 633,455 shares after the transaction. Additional indirect holdings are shown in several family trusts, and a separate line reflects 5,533,794 shares held directly as of the same date.
Concentra Group Holdings Parent, Inc. director Robert A. Ortenzio reported an indirect open-market sale of 130,000 shares of Common Stock on June 1, 2026 by The Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio.
The shares were sold at a weighted average price of $25.0002 per share, with individual sale prices ranging from $25.00 to $25.03. Following this transaction, the trust still holds 763,455 shares of Common Stock.
Additional entries show indirect holdings of 226,286 shares in each of several 2014 trusts and 1,032,115 shares in the Robert A. Ortenzio Descendants Trust, as well as a separate direct holding of 5,533,794 shares of Common Stock.
Concentra Group Holdings Parent, Inc. director Robert A. Ortenzio reported an indirect open-market sale of 130,000 shares of common stock at $25.00 per share. The sale was made by The Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio, which held 893,455 shares afterward. Additional indirect family trusts and direct holdings include 5,533,794 shares reported as directly owned.
Concentra Group Holdings Parent, Inc. reported an insider transaction by its Chief Executive Officer and director involving a gift of common stock. On December 17, 2025, the reporting person made a gift of 89,081 shares of common stock to the Cynthia Lee Newton Beneficiary Trust, recorded at a price of $0 per share under transaction code G.
Following the transaction, the reporting person holds 393,750 shares of common stock directly. The Form 4 also shows 89,081 shares held indirectly through the Cynthia Lee Newton Beneficiary Trust. The filing explains that the reporting person is not a trustee of the trust, does not control its investments, and therefore has no reportable pecuniary interest in the shares held by the trust.
Concentra Group Holdings Parent, Inc. executive Timothy F. Ryan reported a routine share withholding related to equity compensation. On 11/26/2025, 5,903 shares of common stock were disposed of at $21.04 per share under transaction code “F,” indicating shares were withheld to cover tax obligations from the vesting of restricted stock. After this transaction, he beneficially owned 114,097 shares of common stock directly. Ryan serves as Executive Vice President & Chief Legal Counsel, and this filing reflects administrative management of taxes on equity awards rather than an open-market sale.
Concentra Group Holdings Parent, Inc. reported an insider share disposition by one of its executives. On 11/26/2025, an officer disposed of 3,935 shares of common stock at $21.04 per share, leaving 76,163 shares beneficially owned after the transaction. The filing classifies the transaction under code F, and the explanation states that the shares were withheld to satisfy tax obligations arising from the vesting of restricted stock. The reporting person serves as Executive Vice President and Chief Operating Officer, Onsite Health & Telemedicine, and the ownership is reported as held directly.
Concentra Group Holdings Parent, Inc. reported an insider share transaction by an executive officer. On 11/26/2025, the Executive Vice President and Chief Accounting Officer had 5,903 shares of common stock withheld at a price of $21.04 per share to cover tax obligations from the vesting of restricted stock. After this tax withholding, the officer beneficially owned 114,097 shares of common stock directly.
Concentra Group Holdings Parent, Inc. reported an insider equity transaction by an executive officer. On 11/26/2025, common stock totaling 5,903 shares was disposed of at a price of $21.04 per share. The filing explains that these shares were withheld to cover tax obligations from the vesting of restricted stock, rather than an open-market sale. After this tax withholding, the reporting person beneficially owned 114,097 shares of common stock directly.
Concentra Group Holdings Parent, Inc. reported an insider transaction by its Executive Vice President and Chief Operating Officer - East. On 11/26/2025, 6,449 shares of common stock were disposed of at a price of $21.04 per share, coded as an "F" transaction, which means the shares were withheld to cover tax obligations arising from the vesting of restricted stock rather than an open market sale. Following this tax-withholding event, the executive directly beneficially owned 113,551 shares of Concentra common stock.
Concentra Group Holdings Parent, Inc. insider reports tax-related share withholding. An executive officer reported a Form 4 transaction involving the company’s common stock on 11/26/2025. A total of 5,903 shares of common stock were disposed of in a transaction coded “F,” meaning the shares were withheld by the company to satisfy tax obligations triggered by the vesting of restricted stock, rather than sold on the open market.
After this tax-withholding event, the reporting person beneficially owns 114,097 shares of Concentra Group Holdings Parent, Inc. common stock in direct ownership form. The filer serves as Executive Vice President, Chief Reimbursement & Government Relations Officer, and filed as a single reporting person.
Concentra Group Holdings Parent, Inc. insider trading report: A company officer reported a routine share withholding related to equity compensation. On 11/26/2025, 17,708 shares of common stock were disposed of at $21.04 per share under transaction code "F," which indicates shares were withheld to cover tax obligations from the vesting of restricted stock. After this transaction, the reporting person directly beneficially owned 342,292 shares of common stock. The reporting person serves as President & Chief Financial Officer of Concentra Group Holdings Parent, Inc.
Concentra Group Holdings Parent, Inc. reported an insider transaction by its Executive Vice President, Chief Marketing and Innovation Officer. On 11/26/2025, the officer had 5,903 shares of common stock disposed of at $21.04 per share, coded as an "F" transaction, meaning the shares were withheld to cover tax obligations from the vesting of restricted stock. After this tax withholding, the officer directly beneficially owned 114,097 shares of Concentra common stock.
Concentra Group Holdings Parent, Inc. reported an insider equity transaction by its Executive Vice President, Chief Digital & Data Officer. On 11/26/2025, the officer had 6,428 shares of common stock withheld at a price of $21.04 per share to cover tax obligations related to the vesting of restricted stock. After this tax withholding, the officer directly beneficially owns 113,572 shares of common stock. This type of transaction is administrative and does not represent an open-market purchase or sale.
Concentra Group Holdings Parent, Inc. reported an insider transaction by an executive officer. On 11/26/2025, the Executive Vice President, Chief Growth & Customer Officer had 5,903 shares of common stock withheld and disposed of at $21.04 per share to cover tax obligations from the vesting of restricted stock. After this tax withholding, the officer directly beneficially owned 114,097 shares of Concentra common stock.
Concentra Group Holdings Parent, Inc. executive shares were adjusted in connection with equity compensation. On 11/26/2025, an officer identified as the Executive Vice President and Chief Medical Officer reported a Form 4 transaction in the company’s common stock. A total of 6,540 shares of common stock were disposed of at $21.04 per share under transaction code F, which indicates shares were withheld to cover tax obligations arising from the vesting of restricted stock.
After this tax withholding event, the reporting person directly beneficially owned 113,460 shares of Concentra Group Holdings Parent, Inc. common stock. The filing reflects an administrative adjustment related to equity compensation rather than an open‑market purchase or sale.
Concentra Group Holdings Parent, Inc. (CON) director reported an insider stock transfer. On 11/25/2025, the reporting person made a bona fide gift of 100,000 shares of common stock, shown with transaction code G and a price of $0 per share, which reflects the nature of a gift rather than a sale.
After this transaction, the director directly held 5,433,794 shares of common stock. The report also lists additional indirect beneficial ownership through several family trusts, including 1,023,455 shares held by The Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio and 1,032,115 shares held by the Robert A. Ortenzio Descendants Trust, plus three 2014 trusts each holding 226,286 shares for individual beneficiaries.
Concentra Group Holdings Parent, Inc. (CON) reported a Form 4 showing an equity award to an executive. On 11/04/2025, the officer received 40,000 shares of restricted stock at $0. The grant will vest in equal annual installments over four years. After this transaction, the reporting person beneficially owned 80,098 shares, held directly. The executive’s title is Executive Vice President, Chief Operating Officer Onsite Health & Telemedicine.
Concentra Group Holdings Parent, Inc. (CON) reported an insider equity award. On 11/04/2025, a company officer received 60,000 shares of restricted stock at $0, increasing directly held common stock to 120,000 shares after the transaction. The award will vest in equal annual installments over four years.
The reporting person serves as Executive Vice President, Chief Operating Officer - East. This filing reflects a compensation grant rather than an open‑market purchase.
Concentra Group Holdings Parent, Inc. disclosed an officer equity award on Form 4. The President & Chief Financial Officer received 180,000 shares of restricted common stock on 11/04/2025 at a reported price of $0. The award will vest in equal annual installments over four years.
Following this grant, the officer’s beneficial ownership stands at 360,000 shares, held directly. This filing reflects routine executive equity compensation designed to align leadership with shareholders through multi‑year vesting.
Concentra Group Holdings Parent, Inc. reported a Form 4 showing an officer received a grant of 60,000 shares of common stock on November 4, 2025 at $0, increasing beneficial ownership to 120,000 shares, held directly. The award is restricted stock that vests in equal annual installments over four years. The officer’s title is Executive Vice President, Chief Clinical Services Officer.
Concentra Group Holdings Parent, Inc. (CON) disclosed a Form 4 showing a director acquired 7,748 shares of common stock as a restricted stock grant on November 4, 2025.
The restricted stock will vest in full on November 4, 2026, subject to certain exceptions. Following the transaction, the reporting person beneficially owns 74,000 shares directly. The grant was reported at a price of $0 per share.
Concentra Group Holdings Parent, Inc. (CON) reported an insider equity award. The company’s Chief Executive Officer and Director acquired 225,000 shares of common stock on 11/04/2025 via a grant coded “A”. The filing lists a $0 price, consistent with a restricted stock award.
The award is described as restricted stock that will vest in equal annual installments over four years. Following this transaction, the reporting person beneficially owned 482,831 shares, held directly.
Concentra Group Holdings Parent, Inc. (CON) reported an insider equity award. Executive Vice President & Chief Legal Counsel Timothy F. Ryan acquired 60,000 shares of common stock on 11/04/2025 as a restricted stock grant at $0.
The award will vest in equal annual installments over four years. Following the grant, Ryan beneficially owned 120,000 shares, held directly.
Concentra Group Holdings Parent (CON) reported a director equity award on a Form 4. On November 4, 2025, the director received two grants of common stock: 7,748 shares that vest in equal annual installments over five years, and 7,748 shares that vest in full on November 4, 2026, subject to certain exceptions. The reported transaction price was $0, reflecting restricted stock awards. Following these grants, the director beneficially owns 15,496 shares, held directly.
Concentra Group Holdings Parent, Inc. (CON) reported an insider equity grant. On November 4, 2025, an officer acquired 60,000 shares of common stock as a restricted stock award at $0, scheduled to vest in equal annual installments over four years.
After this grant, the reporting person beneficially owns 120,000 shares, held directly. The officer’s title is Executive Vice President, Chief Operating Officer - West.
Concentra Group Holdings Parent, Inc. reported an insider equity award to a director.
On 11/04/2025, 7,748 shares of common stock were acquired at $0 (Transaction Code A). Per the footnote, this was a grant of restricted stock that will vest in full on November 4, 2026.
Following the grant, 5,533,794 shares were beneficially owned directly. Indirect holdings include 1,023,455 shares by The Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio and 1,032,115 shares by the Robert A. Ortenzio Descendants Trust.
Concentra Group Holdings Parent, Inc. (CON) reported an insider equity award on a Form 4. The company’s Executive Vice President, Chief Marketing and Innovation Officer received 60,000 shares of common stock on 11/04/2025 via a restricted stock grant at $0 per share.
The restricted stock will vest in equal annual installments over four years. After this grant, the reporting person beneficially owns 120,000 shares, held directly.
Concentra Group Holdings Parent, Inc. disclosed a Form 4 for its Senior Vice President, Human Resources, showing an award of 40,000 shares of common stock on 11/04/2025. The award is restricted stock that will vest in equal annual installments over four years at a price of $0.
After this grant, the reporting person beneficially owns 80,000 shares, held directly.
Concentra Group Holdings Parent, Inc. (CON) insider transaction: On 11/04/2025, the Executive Vice President and Chief Accounting Officer received a grant of 60,000 shares of common stock at $0 as restricted stock. The award will vest in equal annual installments over four years.
Following this grant, the officer beneficially owns 120,000 shares, held directly.
Concentra Group Holdings Parent, Inc. (CON) filed a Form 4 reporting an executive equity grant. On 11/04/2025, the Executive Vice President and Chief Medical Officer received 60,000 shares of common stock as a restricted stock award at a reported price of $0.
The restricted stock will vest in equal annual installments over four years. Following this grant, the reporting person beneficially owns 120,000 shares, held directly.
Concentra Group Holdings Parent, Inc. (CON) reported an insider equity grant. On 11/04/2025, an officer received 60,000 shares of common stock at a price of $0 under a restricted stock award. Following the grant, the officer beneficially owns 120,000 shares, held directly.
The award is described as restricted stock that will vest in equal annual installments over four years. The reporting person is identified as Executive Vice President, Chief Growth & Customer Officer. The transaction was coded as an acquisition of securities.
Concentra Group Holdings Parent (CON) reported a director’s equity award on Form 4. On 11/04/2025, the reporting person acquired 7,748 shares of Common Stock at $0, disclosed as a grant of restricted stock. Following the transaction, the director beneficially owns 20,740 shares, held directly.
The restricted stock grant will vest in full on November 4, 2026, subject to stated exceptions. This filing reflects an equity compensation event rather than an open‑market purchase.
Concentra Group Holdings Parent, Inc. disclosed an insider equity grant. On 11/04/2025, an officer received 60,000 shares of common stock as restricted stock at $0 under a grant that vests in equal annual installments over four years. Following the award, the reporting person beneficially owns 120,000 shares, held directly. The filer is the company’s Executive Vice President, Chief Digital & Data Officer. Transaction code: A (grant).
Concentra Group Holdings Parent, Inc. (CON) reported an insider equity grant. A company officer filed a Form 4 showing acquisition of 60,000 shares of common stock as a restricted stock grant at $0 on 11/04/2025. Following this grant, the officer directly beneficially owns 120,000 shares. The award will vest in equal annual installments over four years.
Concentra Group Holdings Parent, Inc. (CON) disclosed an insider equity grant. A director received 7,748 shares of common stock on 11/04/2025 at $0 as a restricted stock award that will vest in full on 11/04/2026.
Following this grant, the reporting person beneficially owns 20,740 shares, held directly.
Concentra Group Holdings Parent, Inc. (CON) reported a director equity award on a Form 4. On 11/04/2025, the director acquired 15,496 shares of common stock via two restricted stock grants at a stated price of $0.
One grant covered 7,748 shares that vest in equal annual installments over five years. A second grant covered 7,748 shares that, subject to certain exceptions, vest in full on November 4, 2026, the first anniversary of the grant date. Following these grants, the Form 4 shows 15,496 shares beneficially owned directly.